Crossmark

Modeling the Effect of the Selective S1P1 Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes

Crossref DOI link: https://doi.org/10.1007/s11095-016-2087-x

Published Online: 2016-12-27

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lott, Dominik

Krause, Andreas

Seemayer, Christian A.

Strasser, Daniel S.

Dingemanse, Jasper

Lehr, Thorsten
Funding

Funding for this research was provided by:

Actelion Pharmaceuticals
License Information

License valid from 2016-12-27